In addition, lncPVT1 regulates the sensitivity of pancreatic cancer cells to gemcitabine by inhibiting enhancer of zeste homolog-2 (EZH2) at polycomb repressive complex 2 (PRC2), where EZH2 upregulates the expression of lncPVT1. Here, EZH2 is linked to pancreatic neoplasm.